权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Bridging Income Generation with Group Integrated Care (BIGPIC)

通过团体综合护理 (BIGPIC) 架起创收桥梁

基本信息

批准号：
8911042
负责人：
Rajesh Vedanthan
金额：
$ 73.99万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-04-01 至 2020-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8911042
关键词：
Address African Blood Pressure Cardiovascular Diseases Cardiovascular system Caring Cessation of life Characteristics Chronic Disease Clinical Cluster randomized trial Communities Country Development Diabetes Mellitus Economic Burden Effectiveness Effectiveness of Interventions Ensure Focus Groups Generations Goals Government Health Health Services Accessibility Hypertension Income Individual Intervention Kenya Knowledge Mediating Mediation Medical Modeling Morbidity - disease rate Outcome Outcome Measure Patients Population Prediabetes syndrome Principal Investigator Qualitative Research Quality of Care Research Research Methodology Research Personnel Research Project Grants Research Technics Resources Risk Factors Risk Reduction Rural Rural Health Savings Self Efficacy Social Network Social support Staging Testing Trust Visit Vulnerable Populations Work arm blood pressure regulation cardiovascular disorder risk cardiovascular risk factor clinical care cohesion contextual factors cost cost effective cost effectiveness design diabetes risk diabetic disability-adjusted life years experience health economics implementation research improved innovation knowledge base member mortality novel primary outcome public health relevance secondary outcome trial comparing

项目摘要

DESCRIPTION (provided by applicant): Bridging Income Generation with Group Integrated Care (BIGPIC) Cardiovascular disease (CVD) is the leading cause of mortality in the world. Diabetes, a major risk factor for CVD, is increasingly prevalent and responsible for substantial cardiovascular morbidity and mortality. Elevated blood pressure (BP) increases CVD risk among individuals with diabetes and pre-diabetes; BP control is therefore a powerful way to reduce CVD risk. Cost-effective, context-specific, and culturally appropriate interventions are critical, and both group medical visits and microfinance have the potential to achieve this. In partnership with the Government of Kenya, the Academic Model Providing Access to Healthcare Partnership has expanded its clinical scope of work in rural western Kenya to include diabetes and hypertension, and has piloted group care and microfinance initiatives with promising early results. However, the effectiveness of these strategies individually, and in combination, on improving CVD risk is not known. Thus, the overall objective of this proposal is to utilize a transdisciplinary implementation research approach to address the challenge of reducing CVD risk in low-resource settings. Specifically, we propose to test the hypothesis that group medical visits integrated into microfinance groups will be effective and cost-effective in reducing CVD risk among individuals with diabetes and at increased risk for diabetes in western Kenya. We further hypothesize that changes in social network characteristics may mediate the impact of these interventions, and that baseline social network characteristics may moderate the impact. Aim 1 is to identify contextual factors, facilitators, and barriers that may impact integration of group medical visits and microfinance groups in this setting, using novel qualitative research techniques. We will then design a contextually and culturally appropriate integrated group medical visit-microfinance model for CVD risk reduction. Aim 2 is to evaluate the effectiveness of group medical visits and microfinance groups for CVD risk reduction among individuals with diabetes or at increased risk of diabetes, by conducting a four-arm cluster randomized trial comparing: 1) usual clinical care; 2) usual clinical care plus microfinance groups only; 3) group medical visits only; and 4) group medical visits integrated into microfinance groups. The primary outcome will be one-year change in systolic BP, and a key secondary outcome will be change in QRISK2 CVD risk score. We will also conduct mediation analysis and moderation analysis to evaluate the influence of social network characteristics on intervention outcomes. Aim 3 is to evaluate the incremental cost-effectiveness of each intervention arm of the trial. The research will be accomplished by an Early Stage Principal Investigator with extensive experience in implementation research in low-resource settings, supported by a transdisciplinary team of investigators with diverse and complementary expertise. Our goal is to add to the existing knowledge base of innovative, scalable, and sustainable strategies to reduce CVD risk in diabetes and other chronic diseases in low-resource settings worldwide.